ACS Infectious Diseases

Papers
(The H4-Index of ACS Infectious Diseases is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Rickettsia Aglow: A Fluorescence Assay and Machine Learning Model to Identify Inhibitors of Intracellular Infection144
Learning from COVID-19 to Tackle Antibiotic Resistance86
Transcriptomics Analysis Uncovers Transient Ceftazidime Tolerance in Burkholderia Biofilms75
Effect of Micro-Patterned Mucin on Quinolone and Rhamnolipid Profiles of Mucoid Pseudomonas aeruginosa under Antibiotic Stress74
Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-1969
Genome-Wide Libraries for Protozoan Pathogen Drug Target Screening Using Yeast Surface Display69
Issue Editorial Masthead64
A Long Residence Time Enoyl-Reductase Inhibitor Explores an Extended Binding Region with Isoenzyme-Dependent Tautomer Adaptation and Differential Substrate-Binding Loop Closure60
Phosphate Ions Alter the Binding of Daptomycin to Living Bacterial Cell Surfaces56
Students Against Superbugs (SAS) Africa52
Antimicrobial Activity of Trigonelline Hydrochloride Against Pseudomonas aeruginosa and Its Quorum-Sensing Regulated Molecular Mechanisms on Biofilm Formation and Virulence52
Binding and Sliding Dynamics of the Hepatitis C Virus Polymerase: Hunting the 3′ Terminus52
Correction to “A Bifunctional Chemical Reporter for in Situ Analysis of Cell Envelope Glycan Recycling in Mycobacteria”51
Diaryl Ureas as an Antiprotozoal Chemotype50
Chitosan-Coated Silver Nanoparticles Inhibit Adherence and Biofilm Formation of Uropathogenic Escherichia coli50
Call for Papers: Combating Tuberculosis: Obstacles, Innovations, and the Road Ahead47
Implications of Mycobacterium tuberculosis Metabolic Adaptability on Drug Discovery and Development46
Pyrido-Dibemequine Metabolites Exhibit Improved Druglike Features, Inhibit Hemozoin Formation in Plasmodium falciparum, and Synergize with Clinical Antimalarials44
Correction to “Target-Based Design of Promysalin Analogs Identifies a New Putative Binding Cleft in Succinate Dehydrogenase”40
Dihydroartemisinin Disrupts Zinc Homeostasis in Plasmodium falciparum To Potentiate Its Antimalarial Action via Pyknosis37
Synthesis and Application of Rare Deoxy Amino l-Sugar Analogues to Probe Glycans in Pathogenic Bacteria37
Raman Fingerprints of SARS-CoV-2 Omicron Subvariants: Molecular Roots of Virological Characteristics and Evolutionary Directions37
Issue Publication Information36
Issue Editorial Masthead36
Salicylanilides Reduce SARS-CoV-2 Replication and Suppress Induction of Inflammatory Cytokines in a Rodent Model35
The Acinetobacter baumannii Autotransporter Adhesin Ata Recognizes Host Glycans as High-Affinity Receptors35
3-Position Biaryl Endochin-like Quinolones with Enhanced Antimalarial Performance35
Etiopathology, Epidemiology, Diagnosis, and Treatment of Fungal Keratitis34
Phenotypic Landscape of Immune Cells in Sepsis: Insights from High-Dimensional Mass Cytometry31
Celebrating a Decade of Trailblazing Research─Collection of Highly Cited Articles Each Year from ACS Infectious Diseases31
Investigating Penetration and Antimicrobial Activity of Vector-Bicycle Conjugates30
0.13579797744751